Related Experiment Video

Updated: Jun 1, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

[Connective tissue growth factor mediates high glucose-induced down-regulation of podocalyxin expression in mouse

Jun Zhang1, Ping-hua Li, Lei Yang

  • 1Department of Nephrology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.

Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University
|May 24, 2011
PubMed
Abstract

Insights

Connective tissue growth factor (CTGF) worsens high glucose-induced podocyte damage by reducing podocalyxin levels via the ERK1/2 pathway. CTGF-specific siRNA offers potential for treating diabetic nephropathy.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Diabetic Complications

Background:

  • Diabetic nephropathy is a leading cause of kidney failure.
  • Podocyte injury is a key event in diabetic nephropathy pathogenesis.
  • Connective tissue growth factor (CTGF) is implicated in kidney disease.

Purpose of the Study:

  • To investigate the effect of CTGF on podocalyxin expression in high glucose-exposed mouse podocytes.
  • To explore the role of the ERK1/2 pathway in CTGF-mediated podocyte damage.
  • To assess the therapeutic potential of CTGF inhibition.

Main Methods:

  • Mouse podocytes were cultured under normal, high glucose, and iso-osmolar conditions.
  • Small interfering RNA (siRNA) targeting CTGF was used to inhibit its expression.
  • Western blotting was employed to measure protein levels of podocalyxin, CTGF, and phosphorylated ERK1/2.

Main Results:

  • High glucose significantly decreased podocalyxin and increased CTGF expression.
  • ERK1/2 phosphorylation was activated by high glucose exposure.
  • CTGF-specific siRNA transfection attenuated high glucose-induced changes.

Conclusions:

  • CTGF mediates high glucose-induced podocyte injury by downregulating podocalyxin through the ERK1/2 pathway.
  • CTGF inhibition using siRNA shows promise in alleviating podocyte damage.
  • Targeting CTGF may represent a novel therapeutic strategy for diabetic nephropathy.

Related Concept Videos

Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...